US Stock MarketDetailed Quotes

SAVA Cassava Sciences

Watchlist
  • 19.640
  • -1.550-7.31%
Close Apr 19 16:00 ET
  • 19.790
  • +0.150+0.76%
Post 19:58 ET
849.35MMarket Cap-8465P/E (TTM)

About Cassava Sciences Company

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Company Profile

SymbolSAVA
Company NameCassava Sciences
Listing DateJul 14, 2000
Issue Price12.00
Founded1998
CEOMr. Remi Barbier
MarketNASDAQ
Employees29
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6801 North Capital of Texas Highway,Suite 300
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78731
Phone1-512-501-2444

Company Executives

  • Name
  • Position
  • Salary
  • Remi Barbier
  • Chairman of the Board, President and Chief Executive Officer
  • 6.26M
  • Dr. James W. Kupiec, M.D.
  • Chief Medical Officer
  • 2.97M
  • Eric Schoen
  • Chief Financial Officer
  • 2.99M
  • R. Christopher Cook
  • Senior Vice President and General Counsel
  • 1.27M
  • Sanford R. Robertson
  • Lead Independent Director
  • 546.16K
  • Robert Anderson, Jr
  • Independent Director
  • 474.50K
  • Dr. Claude Nicaise,M.D.
  • Independent Director
  • 474.50K
  • Pierre Gravier
  • Independent Director
  • 474.50K
  • Michael J. O'Donnell, Esq.
  • Independent Director
  • 438.42K
  • Dr. Robert Z. Gussin, PhD
  • Independent Director
  • 546.16K
  • Dr. Patrick J. Scannon,M.D.,PhD
  • Independent Director
  • 438.42K
  • Richard J. Barry
  • Independent Director
  • 546.16K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg